MJM Radiology: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MJM Radiology
Largest movements
- Cash +€110,380
up €110,380 (+237%), from €46,642 to €157,022
mainly Net result for the year (+€156,229) and Depreciation (+€8,434)
- Tangible fixed assets +€40,365
new in 2025: €40,365
of which Plant, machinery and equipment: +€39,458
- Receivables within one year +€9,673
new in 2025: €9,673
of which Other amounts receivable: +€6,703
- Profit (loss) carried forward +€156,229
up €156,229 (+361%), from €43,232 to €199,462
- Other debts +€4,933
up €4,933 (+266%), from €1,857 to €6,790
- Gross operating margin +€176,226
up €176,226 (+378%), from €46,666 to €222,892
- Taxes +€58,122
new in 2025: €58,122
- Depreciation +€5,000
up €5,000 (+146%), from €3,434 to €8,434
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €46,642 | €207,787 | +€161,145 | +345% |
| Fixed assets | 21/28 | - | €40,365 | +€40,365 | |
| Tangible fixed assets | 22/27 | - | €40,365 | +€40,365 | |
| Plant, machinery and equipment | 23 | - | €39,458 | +€39,458 | |
| Furniture and vehicles | 24 | - | €908 | +€908 | |
| Current assets | 29/58 | €46,642 | €167,422 | +€120,780 | +259% |
| Amounts receivable within one year | 40/41 | - | €9,673 | +€9,673 | |
| Trade receivables | 40 | - | €2,970 | +€2,970 | |
| Other amounts receivable | 41 | - | €6,703 | +€6,703 | |
| Cash at bank and in hand | 54/58 | €46,642 | €157,022 | +€110,380 | +237% |
| Deferred charges and accrued income | 490/1 | - | €727 | +€727 | |
| Total equity and liabilities | 10/49 | €46,642 | €207,787 | +€161,145 | +345% |
| Equity | 10/15 | €44,732 | €200,962 | +€156,229 | +349% |
| Contributions | 10/11 | €1,500 | €1,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €43,232 | €199,462 | +€156,229 | +361% |
| Amounts payable | 17/49 | €1,909 | €6,825 | +€4,916 | +257% |
| Amounts payable within one year | 42/48 | €1,909 | €6,825 | +€4,916 | +257% |
| Trade debts | 44 | €53 | €35 | -€17 | -32.8% |
| Suppliers | 440/4 | €53 | €35 | -€17 | -32.8% |
| Other amounts payable | 47/48 | €1,857 | €6,790 | +€4,933 | +266% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,434 | €8,434 | +€5,000 | +146% |
| Other operating charges | 640/8 | - | €55 | +€55 | |
| Gross operating margin | 9900 | €46,666 | €222,892 | +€176,226 | +378% |
| Operating profit (loss) | 9901 | €43,232 | €214,403 | +€171,171 | +396% |
| Financial charges | 65/66B | - | €51 | +€51 | |
| Recurring financial charges | 65 | - | €51 | +€51 | |
| Profit (loss) for the period before taxes | 9903 | €43,232 | €214,352 | +€171,120 | +396% |
| Income taxes | 67/77 | - | €58,122 | +€58,122 | |
| Profit (loss) for the period | 9904 | €43,232 | €156,229 | +€112,997 | +261% |
| Profit (loss) for the period to be appropriated | 9905 | €43,232 | €156,229 | +€112,997 | +261% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.